Elucidation of Hsa-miR-98's Role in Oncogenicity and Oxidative Stress in Breast Cancer Cell Lines
The role of miR -98 is controversial in the literature which we aimed to clarify in breast cancer cell lines. To elucidate the role of miR-98, mimic and inhibitor were transfected into MCF-7and MDA-MB-231 cell lines. Q-RT-PCR was used to analyze Wnt pathway gene expression. Function analysis including wound healing, and determining oxidative stress parameters were conducted. miR-98 was up-regulated in most breast cancer tissue databases. Bioinformatics analysis target prediction and enrichment analysis clarified that miR-98 is incorporated in oxidative stress pathway. It targets several genes from which HIF-1A and VEGFA which were selected for real time analysis. Q-RT- PCR results revealed that HIF-1A and VEGFA were non-significantly increased upon inhibition of miR-98 in MCF-7 while HIF-1A and VEGFA were significantly decreased upon inhibition of miR-98 in MDA-MB-231. On the other hand, the level of catalase which is ROS tracker enzyme in cell lysate of MCF-7 was significantly increased upon inhibition of miR-98. miR-98 triggered the cells of MCF-7 and MDA-MB-231 to acquire great proliferative and migrative power assisting it to heal the manufactured scratch in both cell lines as compared to control. Overall, our result point out that miR-98 acts as oncomiR in breast cancer cell lines.
Authors
- Ghada H. Elsayed (ORCID: https://orcid.org/0000-0002-5505-217X)
- Mahmoud ElHefnawi (ORCID: https://orcid.org/0000-0003-3896-6911)
- Shaymaa M.M. Yahya (ORCID: https://orcid.org/0000-0003-1526-9603)
- Nadia M. El‐Beih
- Enas A. El‐Hussieny (ORCID: https://orcid.org/0000-0002-3885-8729)
- Fatma M. M. Tamam
Institutions
- National Research Centre (EG)
Publication Details
- Journal
- Egyptian Academic Journal of Biological Sciences. B, Zoology
- Published
- 2025-03-16
- DOI
- https://doi.org/10.21608/eajbsz.2025.416999
- Citations
- 1
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.94